Henry Schein, Inc.  

(Public, NASDAQ:HSIC)   Watch this stock  
Find more results for HSIC
144.45
+0.21 (0.15%)
Jul 2 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 143.67 - 144.87
52 week 109.34 - 146.45
Open 144.58
Vol / Avg. 427,397.00/405,232.00
Mkt cap 12.08B
P/E 26.38
Div/yield     -
EPS 5.48
Shares 83.62M
Beta 0.84
Inst. own 96%
Aug 3, 2015
Q2 2015 Henry Schein Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jun 23, 2015
Henry Schein Inc at Piper Jaffray Heartland Summit
Jun 22, 2015
Henry Schein Inc Annual Shareholders Meeting
Jun 18, 2015
Henry Schein Inc at Leerink Partners Healthcare Services and HCIT Roundtable
Jun 10, 2015
Henry Schein Inc at William Blair Annual Growth Stock Conference - Webcast
Jun 9, 2015
Henry Schein Inc at Goldman Sachs Healthcare Conference - Webcast
Jun 1, 2015
Henry Schein Inc at Jefferies Global Healthcare Conference
May 27, 2015
Henry Schein Inc at Stifel Dental & Veterinary Conference
May 19, 2015
Henry Schein Inc at UBS Global Healthcare Conference
May 7, 2015
Henry Schein Inc at Deutsche Bank Health Care Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 4.45% 4.76%
Operating margin 6.55% 6.90%
EBITD margin - 8.31%
Return on average assets 7.28% 8.39%
Return on average equity 14.96% 16.65%
Employees 17,500 -
CDP Score - -

Address

135 Duryea Rd
MELVILLE, NY 11747
United States - Map
+1-631-8435500 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Henry Schein, Inc. provides health care products and services to office-based dental animal health and medical practitioners. The Company operates its business through two segments: health care distribution and technology and value-added services. The health care distribution segment distributes consumable products, laboratory products, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins, among others. The Company's global technology and value-added services segment provides software, technology and other value-added services to health care practitioners. Its offerings include practice management software systems for dental and medical practitioners and animal health clinics. Its value-added practice solutions include financial services on a non-recourse basis, e-services, practice technology, network and hardware services, as well as continuing education services for practitioners.

Officers and directors

Stanley M. Bergman Chairman of the Board, Chief Executive Officer
Age: 65
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Steven Paladino CPA Chief Financial Officer, Executive Vice President, Director
Age: 58
Bio & Compensation  - Reuters
James P. Breslawski CPA President, Henry Schein and Chief Executive Officer, Global Dental Group, Director
Age: 61
Bio & Compensation  - Reuters
David C. McKinley President, Medical Group
Age: 62
Bio & Compensation  - Reuters
Bob Minowitz President, International Dental Group
Age: 56
Bio & Compensation  - Reuters
Lonnie Shoff Chief Executive Officer of Global Animal Health and Strategic Partnership Group
Age: 56
Bio & Compensation  - Reuters
Gerald A. Benjamin Chief Administrative Officer, Executive Vice President, Director
Age: 62
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark E. Mlotek Chief Strategic Officer, Executive Vice President, Director
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
James A. Harding Chief Technology Officer, Senior Vice President
Age: 59
Bio & Compensation  - Reuters
Leonard A. David Chief Compliance Officer, Senior Vice President
Age: 66
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance